4-[(Diethylamino)sulfonyl]benzoic acid

CAS : 1213-06-5

Ref. 3D-FD117447

Informations sur le produit

• Nom: 4-[(Diethylamino)sulfonyl]benzoic acid
• Synonymes: 4-(Diethylsulfamoyl)Benzoate, 4-(Diethylsulfamoyl)Benzoic Acid, 4-Carboxy-N, N-diethylbenzenesulfonamide, 4-Diethylsulfamoylbenzoic acid, Antidipsin, Benzoic acid, 4-[(diethylamino)sulfonyl]-, Benzoic acid, p-(diethylsulfamoyl)-, Etamid, Ethamide, Ethebenecid, Ethebenecide, Longacid, N, N-Diethyl-p-sulfamoylbenzoic acid, NSC 49467, Urelim, p-(Diethylsulfamoyl)benzoic acid, p-Carboxy-N,N-diethylbenzenesulfonamide, p-Diethylsulfamylbenzoic acid

Description

4-[(Diethylamino)sulfonyl]benzoic acid (DEASBA) is a diagnostic agent, which is used to identify cancer cells. This drug is often used as an imaging agent for the detection of solid tumours and inflammatory diseases. DEASBA binds to fatty acids, such as tyrosine, preventing their oxidation by tyrosinase and inhibiting the synthesis of melanin. This may lead to a decrease in the size of the tumor or other disease that has been detected. The clinical response was observed in patients with ulcerative colitis and Crohn's disease who were treated with sodium citrate, a molecule that alters the pH of stool and promotes colonic absorption of DEASBA.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 257.31 g/mol
• Formule: C₁₁H₁₅NO₄S
• Degré de pureté: Min. 95%